SPE Capital buys 30% stake in Future Pharma

M&A WATCH- SPE Capital buys 30% stake in Future Pharma: SPE Capital Partners has acquired a 30% stake in Future Pharma Industries (FPI) for EGP 500 mn, SPE Chairman Gamal El Leithy said, according to the local press. The Middle East-focused private equity firm reported in March that it made an undisclosed equity investment in FPI through its SPE AIF I fund. SPE was originally eyeing up to a 40% stake in the Egyptian pharma company. FPI plans to use the proceeds from the transaction to establish six new production lines.